Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04515316 · ClinicalTrials.gov registry record · NA

A Room Temperature Atomic Magnetrode System for Telemetry of Epileptic Seizures

A NA study of Epilepsy, sponsored by University of Colorado, Denver.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT04515316 is a NA study of Epilepsy that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 40 participants, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04515316, a NA study of Epilepsy, is actively recruiting participants, sponsored by University of Colorado, Denver.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

This study is being done to help scientists learn about the use of a device called an atomic magnetometer. The device uses sensors called optically-pumped magnetometers (OPM) which function at room temperature. This research will compare the non-invasive brain imaging application of the OPM sensors to the present SQUID-based cryogenic sensor technique used in conventional Magnetoencephalography (MEG). This study is being conducted in conjunction with the University of Colorado Boulder's Mechanical Engineering Department.

Conditions Studied

Interventions

  • DEVICE OPM sensors
  • DEVICE SQUID sensors

Study Locations (1)

Colorado

  • University of Colorado School of Medicine - Anschutz Medical Campus - Aurora

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2021-03-01
Est. Completion 2025-12-31
Phase NA

Sponsor

University of Colorado, Denver

1,283 total trials

What the Registry Record Tells You About NCT04515316

The ClinicalTrials.gov registry entry for NCT04515316 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (96% lower). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Epilepsy appearing as the primary indexed condition, and to 2 interventions - of which OPM sensors is the first listed.

NCT04515316 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT04515316 about?

NCT04515316 is a clinical study titled "A Room Temperature Atomic Magnetrode System for Telemetry of Epileptic Seizures". This study is being done to help scientists learn about the use of a device called an atomic magnetometer. The device uses sensors called optically-pumped magnetometers (OPM) which function at room temperature. This research will compare the non-invasive brain imaging application of the OPM sensors ...

What is the current status of trial NCT04515316?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2021-03-01. Estimated completion is 2025-12-31.

What conditions does trial NCT04515316 study?

This clinical trial studies the following conditions: Epilepsy.

What interventions are being tested in trial NCT04515316?

The interventions under investigation include: OPM sensors (DEVICE), SQUID sensors (DEVICE).

Who is sponsoring clinical trial NCT04515316?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04515316 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Epilepsy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.